UBS maintains Clorox at Neutral, raises price target to $96 from $91
UBS kept its Neutral rating on Clorox but increased its price target to $96 from $91, suggesting a 6.8% upside from the Nov 2 close of $89.90. Recent analyst price targets for Clorox range from $80 to $99.
How this was made

The 30-second read
Why it matters
The main tradable input is the revised price target ($96 vs $91) while the rating remains Neutral, suggesting incremental support rather than a catalyst.
Market read
Useful for short-term sentiment and positioning, but lacks new fundamental information.
What to watch
The article does not cite any new thesis drivers behind the target change, so traders may discount the update versus catalysts like earnings or guidance.
Background
The piece is an analyst action summary from UBS, not a company disclosure.
Ticker impact
UBS maintained Clorox at Neutral and raised its price target to $96 from $91, implying upside versus the Nov 2 close.
Likely modest upward bias as traders price in the higher target, but follow-through may be capped by the unchanged Neutral rating.
The article provides a specific UBS price-target increase and an implied upside figure, but it is not a new fundamental event like earnings, guidance, or a deal.
Market effects
Limited read-through to consumer staples beyond incremental sentiment for a large household products name.
No direct regional macro or cross-market catalyst described.
Primarily US-listed analyst-target adjustment, with minimal global spillover.
Counterpoint
A higher price target with a Neutral rating may reflect valuation support rather than improved fundamentals, so the market may not re-rate meaningfully.
Key entities
- companyClorox
UBS maintained Neutral and raised its price target to $96 from $91.



